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Abstract: The purpose of this work was to further expand the chemistry of mixed technetium
nitrido-peroxo complexes, a still poorly explored class of compounds containing the Tc(VII) moiety,
[99gTc][Tc(N)(O2)2]. A number of novel complexes of the formula [99gTc][Tc(N)(O2)2(L)] with bidentate
ligands (L) (where L = deprotonated alanine, glycine, proline) were prepared by reacting a solution
of nitrido-technetic(VI) acid with L in the presence of a source of H2O2. Alternatively, the complex
[99gTc][Tc(N)(O2)2X]− (X = Cl, Br) was used as a precursor for substitution reactions where the
halogenide ion was replaced by the bidentate ligand. The new complexes were characterized by
elemental analysis and mass spectroscopy. The preparation of the analogous [99mTc][Tc(N)(O2)2]
moiety, radiolabeled with the metastable isomer Tc-99m, was also studied at a no-carrier-added level,
using S-methyl-N-methyl-dithiocarbazate as the donor of the nitrido nitrogen atoms.
Keywords: technetium; technetium-99m; peroxo complexes; nitrido complexes; nitrido peroxo complexes
1. Introduction
The anionic technetium complex [99gTc][Tc(N)(O2)2Cl]−, reported by Baldas and coworkers a
few decades ago [1], was the first example of a transition compound containing a metal–nitrido
multiple bond (M≡N) tethered to a peroxo (O22−) group. In this remarkable compound, the oxidation
state of the technetium atom is +7 and the resulting coordination arrangement manifests high
solubility and stability in aqueous solution. Previous studies have reported only a few reactions
involving the [99gTc][Tc(N)(O2)2] fragment. In these reactions, a bidentate ligand L (L = 2,2′-bipyridine,
1,10-phenantroline, oxalic acid) coordinated the metal atom without disrupting the [99gTc][Tc(N)(O2)2]
metallic moiety to yield monosubstituted [99gTc][Tc(N)(O2)2(L)] or oxalate-bridged, dinuclear
[99gTc][{Tc(N)(O2)2}2(L’)]2− (L’ = dianionic oxalate) complexes [2].
Despite its interesting properties, the chemistry of the Tc(VII) nitrido-peroxo functional group
still remains poorly investigated. Several potential advantages could be envisaged by exploiting the
distinctive chemical features of the [99gTc][Tc(N)(O2)2] fragment, particularly in an aqueous solution.
As mentioned above, the oxidation state of technetium in [99gTc][Tc(N)(O2)2] is +7, thus identical to
that assigned to the same metal in the tetraoxo anion [99gTc][TcO4]−, which is the most stable species of
technetium in water. Therefore, it is expected that the [99gTc][Tc(N)(O2)2] moiety should be strongly
resistant towards oxidation reactions of the metal center in water and, possibly, only affected by
reduction processes that are less common in an aqueous medium. This redox inertness, comparable to
that of the tetraoxo anion [99gTc][TcO4]−, might confer a higher stability towards hydrolysis in water to
the resulting nitrido-peroxo complexes. However, whereas substitution reactions onto [99gTc][TcO4]−
are quite arduous under mild conditions, the [99gTc][Tc(N)(O2)2] moiety apparently displays a higher
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reactivity. This observation may point towards the use of the [99gTc][Tc(N)(O2)2] group as a convenient
synthon for the preparation of technetium complexes in full aqueous conditions.
Besides the obvious interest in further expanding the knowledge of technetium chemistry [3–10],
there exists a practical interest in exploring the properties of the Tc(VII) nitrido-peroxo core that is
related to the use of technetium complexes as diagnostic imaging agents for single photon emission
tomography (SPECT) [11–14]. A crucial requirement for the preparation of an injectable diagnostic
radiopharmaceutical radiolabeled with the γ-emitting radioisotope Tc-99m is that the reaction should
be carried out under strictly controlled physiological conditions. As previously noted, the observed
high water solubility and redox inertness of the [99gTc][Tc(N)(O2)2] synthon suggests that it could be
conveniently utilized for the development of novel classes of Tc-99m radiopharmaceuticals.
The present study was carried out in two separate steps. Initially, the reactivity of the Tc(VII)
nitrido-peroxo core towards ligand substitution was further evaluated by conducting simple exchange
reactions onto the [99gTc][Tc(N)(O2)2] group using a number of natural amino acids. Then, a procedure
for obtaining the functional moiety [99mTc][Tc(N)(O2)2] radiolabeled with the nuclear isomer Tc-99m,
at the nanomolar concentration scale typically employed in radiopharmaceutical preparations, was
investigated. As a preliminary application of this novel chemistry to the labeling of biologically
relevant molecules, the radiolabeling of the antibody trastuzumab was accomplished by the simple
mixing of the [99mTc][Tc(N)(O2)2] precursor with the protein.
2. Results
Addition of the amino acids proline (HPro), glycine (HGly) and alanine (HAla) to an acetonitrile
solution of [99gTc][Tc(N)(O2)2X]− (X = Cl, Br), in the presence aqueous boric acid, [B(OH)3], yielded the
new complexes of the general formula [99mTc][Tc(N)(O2)2(L)]− (where L indicates the deprotonated
carboxylate form of the corresponding amino acid) in low yield. The resulting bright-orange compounds
were recovered from the reaction solution as salts of the bulky cation [As(C6H5)4]+ by slow evaporation
under an argon stream. When [B(OH)3] was not added to the mixture, no reaction was observed,
a result which suggests that, presumably, the role of this reagent in the process was as halogen (Cl−,
Br−) acceptor from the precursor complex. A higher yield was achieved following another synthetic
route originally proposed by Baldas and coworkers [2]. This procedure first required the in situ
generation of nitrido pertechnic acid, [99mTc][Tc(N)(OH)3]n, by aqueous hydrolysis of the nitrido
complex [99gTc][Tc(N)Cl5]− [15,16]. The subsequent addition of H2O2 led to the formation of an
hypothetical nitrido-peroxo technetic acid, which was further reacted with excess of the appropriate
amino acid to yield the final substituted complexes [99mTc][Tc(N)(O2)2(L)]− (L = deprotonated Pro, Gly
and Ala). Figure 1 illustrates a schematic drawing of these reactions.
Inorganics 2019, 7, x FOR PEER REVIEW 2 of 10 
 
[99gTc][TcO4]− are quite arduous under mild conditions, the [99gTc][Tc(N)(O2)2] moiety apparently 
displays a higher reactivity. This observation may point towards the use of the [99gTc][Tc(N)(O2)2] 
group as a convenient synthon for the preparation of technetium complexes in full aqueous 
conditions. 
Besides the obvious interest in further expanding the knowledge of technetium chemistry [3–
10], there exists a practical interest in exploring the properties of the Tc(VII) nitrido-peroxo core that 
is related to the use of technetium complexes as diagnostic imaging agents for single photon emission 
tomography (SPECT) [11–14]. A crucial requirement for the preparation of an injectable diagnostic 
radiopharmaceutical radiolabeled with the γ-emitting radioisotope Tc-99m is that the reaction should 
be carried out under strictly controlled physiological conditions. As previously noted, the observed 
high water solubility and redox inertness of the [99gTc][Tc(N)(O2)2] synthon suggests that it could be 
conveniently utilized for the development of novel classes of Tc-99m radiopharmaceuticals. 
The present study was carried out in two separate steps. Initially, the reactivity of the Tc(VII) 
nitrido-peroxo core towards ligand substitution was further evaluated by conducting simple 
exchange reactions onto the [99gTc][Tc(N)(O2)2] group using a number of natural amino acids. Then, 
a procedure for obtaining the functional moiety [99mTc][Tc(N)(O2)2] radiolabeled with the nuclear 
isomer Tc-99m, at the nanomolar concentration scale typically employed in radiopharmaceutical 
preparations, was investigated. As a preliminary application of this novel chemistry to the labeling 
of biologically relevant molecules, the radiolabeling of the antibody trastuzumab was accomplished 
by the simple mixing of the [99mTc][Tc(N)(O2)2] precursor with the protein. 
2. Results 
Addition of the amino acids proline (HPro), glycine (HGly) and alanine (HAla) to an acetonitrile 
solution of [99gTc][Tc(N)(O2)2X]− (X = Cl, Br), in the presence aqueous boric acid, [B(OH)3], yielded the 
new complexes of the general formula [99mTc][Tc(N)(O2)2(L)]− (where L indicates the deprotonated 
carboxylate form of the corresponding amino acid) in low yield. The resulting bright-orange 
compounds were recovered from the reaction solution as salts of the bulky cation [As(C6H5)4]+ by 
slow evaporation under an argon stream. When [B(OH)3] was not added to the mixture, no reaction 
was observed, a result which suggests that, presumably, the role of this reagent in the process was as 
halogen (Cl−, Br−) acceptor from the precursor complex. A higher yield was achieved following 
another synthetic route originally proposed by Baldas and coworkers [2]. This procedure first 
required the in situ generation of nitrido pertechnic acid, [99mTc][Tc(N)(OH)3]n, by aqueous hydrolysis 
of the nitrido complex [99gTc][Tc(N)Cl5]− [15,16]. The subsequent addition of H2O2 led to the formation 
of an hypothetical nitrido-peroxo technetic acid, which was further reacted with excess of the 
appropriate amino acid to yield the final substituted complexes [99mTc][Tc(N)(O2)2(L)]− (L = 
deprotonated Pro, Gly and Ala). Figure 1 illustrates a schematic drawing of these reactions. 
 
Figure 1. Schematic diagram of the synthesis of the Tc nitrido-peroxo complexes (a) starting from 
[99gTc][Tc(N)(O2)2X]− (X = Cl, Br) and (b) starting from nitrido pertechnic acid. 
Figure 1. Sche atic diagra of the synthesis of the Tc nitrido-peroxo complexes (a) starting from
[99gTc][Tc(N)(O2)2X]− (X = Cl, Br) and (b) starting from nitrido pertechnic acid.
Inorganics 2019, 7, 142 3 of 10
The chemical composition of the resulting complexes was inferred from data of elemental analyses
and mass spectra. Proton magnetic resonance (PMR) spectra of the complexes are more complex
than those of the free amino acids and a detailed assignment of all protons in these spectra was not
carried out in the present study. However, detection of proton signals provided strong evidence of the
presence of the coordinated amino acid. The spectra of the complexes containing the simplest amino
acids, glycine and alanine, were easier to interpret. In free glycine, the two protons attached to the
α-carbon were equivalent and the PMR spectrum showed a sharp singlet. Upon binding the Tc≡N
group, these two protons lost their equivalence, presumably because of the two possible, syn and anti,
orientations these protons can achieve with respect to the Tc≡N multiple bond. As a result, the PMR
spectrum transformed in a broader multiplet, probably generated by the combination of two doublets,
each corresponding to a single proton. Conversely, the PMR of the alanine derivative approximately
retained the overall structure of the free ligand because of the presence of an asymmetrical α-carbon
bound to a single hydrogen and one methyl group. As a result, the spectrum was roughly composed
of a doublet and of a pseudo-quartet assigned to the methyl group and the hydrogen atom bound
to the α-carbon, respectively. It should be noted that other simple amino acids were tested for their
reactivity towards the [99gTc][Tc(N)(O2)2] moiety and, invariably, the formation of various chemical
species was observed. However, despite many efforts, it was not possible to isolate these products in a
sufficiently purified form to obtain a satisfactory chemical characterization.
Mass spectroscopy was particularly informative. The electrospray ionization mass spectra (ESI-MS)
collected in both positive- and negative-ion modes for all complexes exhibited the same general pattern
(Supplementary Materials). In positive-ion mode, the signals corresponding to the complexes were
not detected, but only those associated with the protonated free amino acids, the [99gTc][Tc(N)(O2)2]
fragment and the counter cation [As(C6H5)4]+, were observed. Conversely, negative-ion mode ESI-MS
showed the main complex ions and the deprotonated free amino acids. These results provide strong
evidence supporting the proposed chemical formulation for these complexes.
Infrared spectra (FT-IR) of the complexes clearly showed the diagnostic strong band, in the interval
1050–1060 cm−1, associated with the ν(Tc≡N) stretching vibration.
It was more challenging to replicate this chemistry under the experimental conditions usually
employed for the preparation of Tc-99m radiopharmaceuticals, where the concentration of the
radionuclide ranges between 10−9 to 10−12 mol dm−3 (no-carrier-added level = n.c.a., also called
“tracer level”). The selected approach was grounded in the results obtained at the macroscopic
level. The formation of the 99mTc nitrido-peroxo fragment, [99mTc][Tc(N)(O2)2], was attempted,
starting from a pre-formed 99mTc nitrido intermediate, which was further reacted with H2O2 in low
concentrations. Baldas and coworkers reported a procedure for preparing the halogeno-nitrido complex
[99mTc][Tc(N)Cl4]− at n.c.a. level through the reaction of sodium azide (NaN3) with [99mTc][TcO4]−
in the presence of the corresponding halogenidric acid (HCl) [17]. Subsequently, it was found that
this procedure was rather cumbersome and difficult to apply to the preparation of Tc-99m nitrido
compounds at tracer level as it required an evaporation step. To ensure the formation of the Tc≡N
multiple bond, a more efficient approach was proposed based on the reaction of [99mTc][TcO4]− with
N-methyl-S-methyl-dithiocarbazate [DTC = H3C−NH−NH−C(=S)SCH3], promoted by the addition
of an appropriate reducing agent (tertiary phosphines or SnCl2). This reaction led to a mixture of
different species that were demonstrated to invariably incorporate the Tc≡N triple bond [18,19]. In this
study, therefore, it was very convenient to utilize these species as pre-formed nitrido intermediates for
the production, at tracer level, of the supposed [99mTc][Tc(N)(O2)2] moiety by simple addition of a
source of hydrogen peroxide to the mixture. In fact, the addition of a few microliters of H2O2 had a
dramatic impact on the profile of the high-performance liquid chromatography (HPLC) chromatogram
of the starting mixture, thus indicating that some reaction had occurred. However, no single product
was identified by HPLC and only a complicated overlap of different peaks was observed. In an
attempt to further characterize this mixture of chemical species, Ultra HPLC (UPLC) was utilized,
following the same methods described previously for the analysis of 99mTc radiopharmaceuticals [20].
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This more powerful chromatographic technique allowed us to achieve a sharper separation of
the various products (Supplementary Materials), but without providing additional hints on their
chemical nature. However, convincing evidence that all species still included a Tc≡N multiple bond
came from the results of the reaction of the mixture with excess of the sodium salt of the ligand
diethyldithiocarbamate {DEDC = [(CH3CH2)2NC(=S)S]−}, which is a common reagent avidly binding
the Tc≡N group. When this ligand was added to the freshly prepared mixture, in combination with some
amount of SnCl2, the well-characterized bis-substituted, nitrido complex [99mTc][Tc(N)(DEDC)2] [21]
was isolated in high yield (77% calculated on the initial 99mTc activity) and characterized by UPLC
(Supplementary Materials).
An unexpected practical application of this chemistry spawned from the observation that the
mixture of Tc-99m species, generated by the addition of peroxides, showed a high reactivity towards
proteins. More precisely, it was found that a simple mixing of the solution containing the hypothetical
mixture of 99mTc-nitrido-peroxo species with a lyophilized formulation of the antibody trastuzumab
allowed for the obtaining of high radiolabeling yields (>90%) of this protein. After flushing the
radioactive solution with an argon stream, the procedure was extremely easy to apply, as it did not
require any preliminary chemical treatment of the antibody for appending to its structure a chelating
group for the radiometal.
3. Discussion
This work was aimed at rediscovering a class of technetium complexes, first described decades ago
by Baldas and coworkers, that was subsequently almost completely abandoned. A characteristic feature
of these complexes is that they contain a technetium atom in some of its highest oxidation states (+6
and +7) and coordinated to a nitrido nitrogen [N3−] group, thus forming a remarkably stable terminal
Tc≡N multiple bond. A relevant example of this type of compounds was provided by complexes
containing the nitrido-peroxo moiety, [99gTc(N)(O2)2], a metallic fragment that can be prepared by
the reaction of nitrido technetic(VI) acid, [99gTc][Tc(N)(OH)3]n, with hydrogen peroxide. This moiety
exhibits high inertness towards hydrolysis in water and, therefore, could be of interest for developing
a new category of 99mTc radiopharmaceuticals. However, despite the ability of the nitrido substituent
to stabilize the highest oxidation states of technetium, this chemistry was not further explored and
only a few complexes comprising the [99gTc(N)(O2)2] fragment have been reported. In particular,
substituted complexes of the type [99gTc(N)(O2)2(L)] where L represents the neutral bidentate ligands
2,2′-bipyridyl (Bipy) and 1,10-phenantroline (Phen), were synthesized and characterized.
Inspired by these results, the present work was undertaken to investigate the reactivity of the
[99gTc(N)(O2)2] synthon towards simple amino acids. The starting precursors [99gTc(N)(O2)2X]−
(X = Cl, Br) was reacted with the amino acids alanine (HAla), glycine (HGly) and proline (HPro)
to yield the corresponding monoanionic complexes [99gTc(N)(O2)2(L)]−, where L stands for the
deprotonated form of these three amino acids. A higher yield was obtained by using nitrido pertechnic
acid, [99gTc][Tc(N)(O2)(OH)2], as the starting material. The structure of the resulting complexes
was inferred from analytical data (Supplementary Materials), which supported the hypothesis
that, in these complexes, the amino acid acts as a bidentate ligand binding the metal through
the deprotonated carboxylic oxygen atom and the neutral amino nitrogen atom. Tentatively, a final
pentagonal-bipyramidal geometry could be assigned to these products comprising an apical Tc≡N
group and two equatorial dioxo ligands as observed in the oxalate-bridged Tc(VII) nitrido-peroxo
dimer [99gTc][{Tc(N)(O2)2}2(Ox)]2− (Ox = [C2O4]4−) [22].
The data collected at the macroscopic level with the long-lived isotope 99gTc led us to speculate
that the observed reactivity of the [99gTc][Tc(N)(O2)2] synthon towards simple amino acids could be
exploited for radiolabeling amino acid-rich biomolecules, such as proteins and antibodies, with the
diagnostic γ-emitting radioisotope 99mTc. To test this hypothesis, a procedure for producing the Tc(VII)
nitrido-peroxo moiety at tracer level (concentration of 99mTc below 10−9 mol dm−3) using the γ-emitting
radionuclide 99mTc was attempted with partially satisfactory results. This procedure was based on a
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well-established method for producing the Tc≡N bond at tracer level [18,19], which was complemented
by the addition of hydrogen peroxide to the solution containing the intermediate 99mTc nitrido precursor.
Evidence that the [99gTc][Tc(N)(O2)2] moiety formed at this very low concentration scale was obtained
only indirectly, as chromatographic analysis revealed the production of a complicate mixture of
compounds (Supplementary Materials). No attempts have been pursued to further characterize the
chemical nature of the components of this mixture that, apparently, are involved in complex equilibria
in solution. However, the addition to this mixture of the ligand diethyl-dithiocarbamate (DEDC =
[(CH3CH2)2NCS2]−), in combination with the reducing agent (SnCl2), led to the formation of the
well-known Tc(V) nitrido complex [99mTc][Tc(N)(DEDC)2), thus suggesting that the Tc≡N bond was
preserved in these reactions.
A preliminary labeling study was carried out using the antibody trastuzumab, which was simply
mixed with an aliquot of the solution containing the mixture of the products supposedly containing
the [99mTc(N)(O2)2] moiety. The results were particularly promising, as the reaction occurred at
room temperature within a few minutes, and the measured labeling yield was almost quantitative.
This application is noteworthy because it could potentially allow for the labeling of proteins without
the need to append any ancillary chelating group to the antibody, as is usually necessary for tethering
the radiometal to a biomolecule [13,14]. However, it should be emphasized that this observation has to
be confirmed by further, larger studies involving different types of antibodies to evaluate their stability
and retention of immunoreactivity after reaction with the radiometal fragment. In fact, it could be
speculated that the observed high labeling yield originated from variations in the chemical composition
of the various 99mTc species present in the reaction mixture and that these modifications might allow
them to attach to the protein at different binding sites. Although this behavior could be beneficial for
increasing the labeling yield, it may cast some concern about the preservation of the antibody’s native
biological properties.
4. Materials and Methods
Caution: Technetium-99g is a weak β−-emitter (Eβ = 0.292 MeV, t1/2 = 2.12 × 105 years).
All manipulations were carried out in a radiochemistry laboratory approved for low-level radioactivity
using HEPA-filtered monitored fume hoods and gloveboxes. When handled in milligram amounts,
99gTc does not present a serious health hazard since common laboratory glassware provides adequate
shielding. Bremsstrahlung is not a significant problem due to the low energy of the β-particles.
However, normal radiation safety procedures must be used at all times, especially with solid samples,
to prevent contamination and inhalation.
The common laboratory solvents were reagent grade and used as purchased. Hydrogen peroxide
(H2O2, 30% w/w in H2O), boric acid (H3BO3, ACS reagent), tetraphenylarsonium chloride hydrate
([As(C6H5)4]Cl, 97%) and the sodium salt of dietyldithiocarbamate were purchased from Merck,
Darmstadt, Germany. Technetium-99g as [99gTc]TcO4][NH4] was obtained from Oak Ridge National
Laboratory (Oak Ridge, TN, USA). The samples were dissolved in water and treated with excess
aqueous ammonia and H2O2 (30% w/w) at 80 ◦C prior to use to eliminate residual [99gTc]TcO2.
Solid [99gTc][TcO4][NH4] was precipitated by slow evaporation under heating at 40 ◦C and then
re-dissolved in water and treated with aqueous KOH to yield crystals of purified [99gTc][TcO4]K
by controlled evaporation under a nitrogen stream. The complexes [99gTc][Tc(N)X4][As(C6H5)4] (X
= Cl, Br) [23–26] and the precursor complex [99gTc][Tc(N)Cl5]Cs2 [27] were prepared by literature
methods. Technetium-99m as [99mTc][TcO4]Na was withdrawn from a Drytec™ 99Mo/99mTc generator
(GE Healthcare) by elution with a physiological solution.
The antibody trastuzumab (Herceptin®) [28,29] was received from Hoffmann-La Roche
(Basel, Switzerland). Before usage, the samples were dissolved in water and purified by passing
through an Ultra-4, 30-kDa column (Amicon®, Sigma Aldrich, St Louis, MO, USA) in six cycles
and then isolated using a centrifuge (HuMax 4k, Human, Wiesbaden, Germany). The concentration
of trastuzumab was adjusted to 1.0 mg/mL using a spectrophotometer (6715 nm UV/Vis, Jenway®,
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Staffordshire, UK). A modified two-day protocol [30] was applied for the freeze-drying of the antibody,
using a Free Zone Stoppering Tray Dryer (Labconco, Kansas City, MO, USA).
Elemental analyses (C, H, N, S) were performed on a Carlo Erba 1106 elemental analyzer. The analysis
of the radioactive technetium-99g was performed as previously described by dissolving weighed samples
in HNO3/H2O2 mixtures and counting the resulting radioactivity in a Packard TRICARB 3000 scintillation
counter. The infrared spectra were recorded on an FT-IR-6000 Spectrometer (Jasko, Easton, MD, USA).
The proton NMR spectra were collected on a Bruker Advance 500 (Bruker BioSpin GmbH, Germany).
The electrospray ionization mass spectra (ESI-MS) of technetium compounds, in the positive- and
negative-ion mode (ca. 10−6 mol dm−3 in methanol solutions), were recorded on a Bruker Esquire HCT
(Bruker Daltonics, Billerica, MA, USA). Instant thin-layer chromatography (ITLC) was performed on
silica-gel (SG) strips, which were subsequently analyzed with a C431200 Cyclone Plus Storage Phosphor
Imager equipped with OptiQuant software (Perkin-Elmer, Shelton CT, Beaconsfield, England) to locate
radioactive spots on the surface. High-performance liquid chromatography (HPLC) was performed on a
Beckman System Gold instrument equipped with a programmable solvent model 126, a sample injection
valve 210A, a scanning detector Module 166, and a radioisotope detector model 170. The HPLC analyses
were carried out using a reversed-phase Agilent precolumn Zorbax 300SB-C18 (4.6 × 12.5 mm) and a
reversed-phase Agilent column Zorbax 300SB- C18 (4.6× 250 mm) at a flow rate of 1.0 mL/min. Ultra HPLC
(UPLC) was performed with a ACQUITY UPLC system (Waters, Milford, MA, USA), equipped with
an autoinjector, UV detector, and gamma flow count detector (Bioscan, Washington, DC, USA) using a
Waters ACQUITY UPLC® BEH column (1.7 mm × 2.1 0 mm). The data collection was accomplished
using the Chromeleon chromatography software package.
4.1. Synthesis of the Complexes
The complexes [99gTc][Tc(N)(O2)2(L)] [As(C6H5)4] (L = Pro, Gly, Ala) were prepared following
two different synthetic routes.
4.1.1. Method (a)
The complexes [99gTc][Tc(N)(O2)2X][As(C6H5)4] (X = Cl, Br) were prepared as reported
previously [2]. These complexes (0.300 mmol) were dissolved in the minimum volume of CH3CN.
To the resulting solution, 0.30 mL of an aqueous solution of boric acid (0.1 M) were added and the
color turned to pale brown. Then, the ligand L (0.600 mmol) was added to the mixture. Upon standing,
the color of the solution darkened slowly. A bright orange precipitate was collected by the slow
evaporation of the solvents under an argon stream. The solid was isolated by filtration and washed
with water and diethyl ether and dried under vacuum. Yield, 23% (X = Cl), 18% (X = Br).
4.1.2. Method (b)
Polymeric nitridotechnetic(VI) acid, [99gTc][Tc(N)(OH)3]n, was prepared as described previously by
the hydrolysis of Cs2[99gTc][Tc(N)Cl5] in water and isolated as a brown precipitate [1,15,16,27]. The brown
solid (84 mg, 0.15 mmol) was dissolved in 0.5 mL of 10% w/w H2O2, followed by the addition of an excess
of the ligand L (0.80 mmol) to yield a pale-yellow solution, which was slightly heated at 30 ◦C for 15 min.
Addition of [As(C6H5)4]Cl (167.52 mg, 0.40 mmol) caused the precipitation of an orange solid, which was
collected by filtration, washed with water and diethyl ether, and then dried under vacuum. Yield, 57%.
4.2. Analytical Characterization
This paragraph reports the most relevant properties of the complexes described in this work.
A more detailed description of the synthetic and analytical methods, the antibody’s labeling procedures
and the determination of the radiochemical purity of the resulting radiolabeled conjugate is reported
in the Supplementary Materials.
[As(C6H5)4]{[99gTc]Tc(N)(O2)2(Pro)]}. Empirical formula: [C29H28N2O6AsTc]. Elemental analysis
[%found (%calculated)]: C, 51.93 (51.64); H, 4.66 (4.18); N, 4.89 (4.15); Tc, 13.95 (14.68). ESI-MS (m/z,
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negative): [M]− calculated for [C5H8N2O6Tc] 291.13, found, 291.05. RP-UPLC: retention time (tR) =
1.66 min. IR (cm−1, KBr): 1050, ν(Tc≡N).
[As(C6H5)4]{[99gTc]Tc(N)(O2)2(Gly)]}. Empirical formula: [C26H24N2O6AsTc]. Elemental analysis
[%found (%calculated)]: C, 50.16 (49.22); H, 4.01 (3.81); N, 4.77 (4.42); Tc, 14.95 (15.60). ESI-MS (m/z,
negative): [M]− calculated for [C2H4N2O6Tc] 251.06, found 251.00. RP-UPLC: retention time (tR) =
1.43 min. IR (cm−1, KBr): 1055, ν(Tc≡N).
[As(C6H5)4]{[99gTc]Tc(N)(O2)2(Ala)]}. Empirical formula: [C27H26N2O6AsTc]. Elemental analysis
[%found (%calculated)]: C, 50.81 (50.01); H, 4.35 (4.04); N, 4.53 (4.32); Tc, 14.88 (15.27). ESI-MS (m/z,
negative): [M]− calculated for [C3H6N2O6Tc] 265.09, found 265.02. RP-UPLC: retention time (tR) =
1.52 min. IR (cm−1, KBr): 1053, ν(Tc≡N).
As a representative example, the ESI-MS and UPLC chromatogram of the complex
[As(C6H5)4]{[99gTc]Tc(N)(O2)2(Gly)]} are reported in Figure 2 below. The complexes are soluble
in CH3CN, CHCl3 and CH2Cl2. When left to stand in non-aqueous solvents and under an argon
atmosphere, their chromatographic profiles did not change significantly over time. However, when
non-anhydrous conditions were used or a few microliters of H2O were added to the solutions, some
decomposition was observed (approximately, 10% after 5 h by HPLC analysis) with the formation of
different species. The nature of these mixtures was not further investigated.
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5. Conclusions
A decade-old technetium chemistry, which was not fully explored in the past, has been rediscovered
in the present study and first evaluated as an efficient tool for producing new classes of complexes.
The characteristic motif permeating the molecular structure of these complexes is formed by the
nitrido-peroxo moiety [99gTc][Tc(N)(O2)2], where a terminal Tc(VII) nitrido core is bound to two peroxo
groups. The resulting metallic fragment exhibits an unexpectedly high stability in water, thus indicating
that the nitrido nitrogen atom is particularly effective in stabilizing the metal in its highest oxidation
states, presumably because of its remarkable pi-donor character. As a first attempt to evaluate the
reactivity of the [99gTc][Tc(N)(O2)2] metallic synthon towards simple molecules, the reaction of some
nitrido-peroxo precursors with natural amino acids was investigated. It was observed that the simple
addition of the selected amino acid to a solution of the [99gTc][Tc(N)(O2)2] fragment elicited a reaction,
although it was difficult to isolate pure products from the reaction mixture. Only with the amino
acids alanine, glycine and proline was it possible to recover products sufficiently pure to allow
for their chemical characterization. Yet, these results, combined with the high stability in aqueous
solution of the [99gTc][Tc(N)(O2)2] group, motivated the extension of this study to investigate whether
it was possible to prepare this class of complexes at the tracer level with the metastable γ-emitting
radioisotope 99mTc. This application would be remarkable because of the important role played
by 99mTc radiopharmaceuticals in diagnostic imaging. Albeit these preliminary results should be
confirmed by further studies, experimental evidence suggests that the [99mTc][Tc(N)(O2)2] moiety can be
generated at the low concentration scale typical of 99mTc preparations. Most interestingly, this precursor,
when mixed with the antibody trastuzumab, reacted quickly and in high yield, thus unearthing an
unexpected route for the efficient labeling of large proteins with 99mTc.
Despite the chemistry of Tc nitrido-peroxo complexes being discovered many years ago, the interest
in this uncommon category of compounds faded away rapidly and their synthesis was not actively
pursued. The present work might contribute to stimulating further investigations in this field and,
possibly, opening new avenues in technetium chemistry.
Supplementary Materials: The following are available online at http://www.mdpi.com/2304-6740/7/12/142/
s1, synthetic procedures, elemental analyses, mass spectra, chromatography; Figures S1–S6. Negative-
/Positive-ion mode ESI-MS of [As(C6H5)4]{[99gTc]Tc(N)(O2)2(Ala)]}, [As(C6H5)4]{[99gTc]Tc(N)(O2)2(Pro)]},
[As(C6H5)4]{[99gTc]Tc(N)(O2)2(Gly)]}; Figure S7. UPLC chromatograms of the novel Tc-99g complexes described
in this study; Figure S8. UPLC chromatogram of the mixture resulting from the preparation of the complex
[99mTc][Tc(N)(O2)2(Gly)]−; Figure S9. UPLC chromatogram of the complex [99mTc][Tc(N)(DEDC)2].
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